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Edited by Horst FeldmannAbstract Toll-like receptors (TLR) detect pathogen-associated
molecular patterns (PAMP) and play a crucial role in triggering
immunity. Due to their large surfaces in direct contact with the
environment, mucosal tissues are the major sites of PAMP-
TLR signalling. How innate and adaptive immunity are triggered
through ﬂagellin–TLR5 interaction is the main focus of the re-
view. In view of recent reports on genetic polymorphism, we will
summarize the impact of TLR5 on the susceptibility to mucosal
infections and on various immuno-pathologies. Finally, the con-
tribution of TLRs in the induction and maintenance of mucosal
homeostasis and commensal discrimination is discussed.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Mucosal surfaces represent main interaction sites with envi-
ronmental microorganisms and antigens. Tight control of
microbial–host interactions is critical to the homeostasis of
mucosal tissues. Colonization and invasion is continuously
prevented by (i) the barrier function of the mucosal epithelia
(tight junctions, glycocalyx and mucus), (ii) the continuous
shedding of epithelial cells, and (iii) chemical factors, i.e.
microbicidal peptides, bacteriostatic proteins and enzymes,
which contribute to the neutralizing or the killing of microbes
[1]. Pathogens that escape this ﬁrst line of defence and invade
the host are facing a second line of defence that consists of res-Abbreviations: DC, dendritic cells; MAMP, microbe-associated mole-
cular pattern; LRR, leucine rich repeat; PAMP, pathogen-associated
molecular pattern; TLR, Toll-like receptor; PRR, pattern-recognition
receptor; TIR, Toll/Interleukin 1 receptor
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doi:10.1016/j.febslet.2006.04.036ident bone marrow-derived cells, i.e. granulocytes, monocytes
and mast cells that also are capable to neutralize and kill the
invading microorganisms. Conserved pathogen-associated
molecular patterns (PAMP) and host pattern-recognition
receptors (PRR) like the Toll-like receptors (TLR) play a cru-
cial role in signalling danger and initiating the host innate re-
sponses. In contrast, the conserved molecular patterns
expressed by the gut microbiota are essential in triggering
TLR-dependent mucosal homeostasis [2–4]. Furthermore, self
tissue-derived molecules produced in mucosa during infection
or injury, such as hyaluronan break-down products, trigger
TLR signalling and, therefore, contribute to protective re-
sponse [5]. This constitutes, at the molecular level, one example
of ‘‘danger signal’’ that extends TLR functionality to identiﬁ-
cation of self alarm signals [6].
Mucosal surfaces can face either a sterile environment as in
the lower airways and the upper uro-genital tract or continu-
ously face environmental microorganisms such as in the gut,
the upper airways and the lower uro-genital tract. These fea-
tures have a profound impact on how microbes are detected
and the outcome of TLR signalling. In addition, mucosal tis-
sues have developed strategies to tolerate commensals and
eliminate pathogens. In mucosal tissues, pathogens trigger
pro-inﬂammatory responses through TLR signalling charac-
terized by the local release in the lumen of a broad spectrum
of anti-microbial factors and in the lamina propria of chemo-
kines that recruit professional phagocytes into mucosal tissues.
Among the recruited cells, dendritic cells (DC) play a special
role since they link innate to adaptive immunity by taking
up microbes at the recruited mucosal site and transporting
them in draining lymph nodes where they can initiate adaptive
immune responses. The ﬁrst sentinel cells exposed to TLR li-
gands are the epithelial cells lining the mucosal surfaces. For
instance, pneumocytes, bronchial epithelial cells, enterocytes
or colonocytes express various sets of TLR and are activated
by the appropriate microbial molecular patterns to generate
a pro-inﬂammatory response. Microbes that are able to cross
the epithelial barrier via speciﬁc transport mechanisms or upon
injury stimulate resident sentinel cells expressing TLR such as
macrophages, mast cells, granulocytes and DCs.
This review focuses on most recent ﬁndings on the contribu-
tion of TLR in mucosal immunity with special emphasis on
ﬂagellin–TLR5 interaction.blished by Elsevier B.V. All rights reserved.
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Flagellin is a structural protein of the ﬂagellum, a surface ﬁl-
ament required for bacterial motility. In pathogenic bacteria,
ﬂagella and chemotaxis machinery contribute to virulence by
providing motility towards niches where infection can take
place (as exempliﬁed for Vibrio cholerae in [7]). There are also
evidence that ﬂagella are important for adhesion and invasion
[8]. The size of bacterial ﬂagellins ranges from 250 to 1250 ami-
no-acids depending on the species [9]. The most studied mole-
cule is the Salmonella typhimurium Flagellin, a 494 amino-acidFig. 1. Molecular mechanisms of TLR5-induced immunity. (A) Organization
mainly of polymerized ﬂagellin. Salmonella typhimurium ﬂagellin consists of
and the hypervariable b-sheets (yellow). The a-helixes regions are required fo
and TLR5 signalling. Flagellin monomer is the molecular pattern detected
universal TLR-speciﬁc adapter molecule MyD88 that activates downstream
transcription of genes involved in innate and adaptive immunity and in pro
immunity. Two major sentinel cells are targeted by TLR5–ﬂagellin activation:
responses by the production of microbicidal molecules and the recruitmen
mucosa. Epithelial cells also stimulate the DC recruitment to start the adapt
also be activated through TLR5, a process known to promote developme
combined with the preference of TLR5-stimulated DCs for activating Th2 re
homing program and an IgA isotype switch to B lymphocytes.long protein, which is organized in two functional domains
(Fig. 1A). The highly conserved 140 amino-terminal and 90
carboxyterminal residues constitute a polymerization and
motility-related domain, while the central part of the molecule
is highly variable among Salmonella serovars and bacterial spe-
cies and forms the domain exposed at the outer surface of the
ﬂagellum [9].
In mammals, the sensing of microbes is achieved by PRRs
like TLRs [10]. TLRs are transmembrane proteins organized
in an extracellular leucine-rich repeat (LRR) module, a mem-
brane spanning motif and a Toll/Interleukin 1 receptor domainof ﬂagellum and ﬂagellin. Motile bacteria produce ﬂagella composed
3 domains: the terminal a-helixes (purple), the central a-helixes (blue),
r ﬁlament architecture and motility functions. (B) Detection of ﬂagellin
by TLR5, speciﬁcally the motif 89–96 (blue helix). TLR5 utilizes the
molecules NF-jB and MAPKs (ERK1/2, p38 and JNK) that turn on
tection against apoptosis. (C) Flagellin-speciﬁc regulation of mucosal
epithelial cells and dendritic cells (DC). Epithelial cells promote innate
t of neutrophils that will eliminate microorganisms interacting with
ive response. Since DC express TLR5, resident and recruited cells may
nt of Th2-type cells. Altogether the epithelial–mucosal environment
sponses elicit mucosa-speciﬁc immune responses imprinting a mucosal
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TLR family play a key role in extracellular and intravacuolar
detection of PAMPs [11]; TLR5 is involved in detection of bac-
terial ﬂagellins [12,13]. Both human and mouse TLR5 recog-
nize similar molecular determinants of ﬂagellin from various
bacteria but, like for the lipopolysaccharide (LPS) detector
TLR4, there are minor diﬀerences in the molecular interactions
between the 2 species [14]. The hypervariable domain of ﬂagel-
lin is not required for TLR5 activation [15,8]. The motif in-
volved in signalling is formed by residues 89–96 of S.
typhimurium ﬂagellin [16,17]. Interestingly, this moiety is hid-
den in the ﬂagellum and becomes accessible only when ﬂagellin
is delivered as a monomer (Fig. 1A–B). The recent elucidation
of the three dimensional structure of TLR3 may provide some
clues on TLR5 function [18,19]. TLR3 LRRs harbouring ami-
no-acids insertions have been associated with the binding of
cognate PAMPs. The extracellular domain of TLR5 is
composed of 20 LRR with ﬁve LRR (7, 9, 14, 15 and 17) con-
taining insertions. Deletion studies suggested that the ﬂagellin-
binding site in human TLR5 is located between residues 386
and 407 of LRR14 [20]. Deletion of TLR5 starting at
LRR14 (392 N-terminal residues or TLR5392-stop) results in
the loss of responsiveness to ﬂagellin [21]. Recently, the Naip5
pathway has been involved in the cytosolic detection of ﬂagel-
lin [22]. It will be important to deﬁne whether this is a mean for
the host to detect intracellular ﬂagellated bacteria.
The TLR5 cascade depends exclusively on the TIR adaptor
molecule MyD88, a molecule essential for most TLRs
(Fig. 1B) [12,13,23]. TLR5 signalling activates nuclear factor
(NF)-jB and mitogen-activated protein kinase (MAPK) path-
ways, i.e. p38, JNK, and ERK1/2, that regulate the transcrip-
tion of genes encoding immune mediators [24–27]. Many
pathogenic bacteria use ﬂagella to establish their niche at the
surface of mucosal tissues. Sensing ﬂagellin by TLR5 may
act as an early detection system that triggers a rapid host re-
sponse [8,28]. Detection of ﬂagellin occurs at the luminal sur-
face of the epithelial cells covering mucosal tissues and not
in intracellular compartments of infected host cell [13,29–31].
How ﬂagellated bacteria physiologically deliver monomeric
ﬂagellin is yet not known. Flagellin may be shed from the bac-
terial surface by host proteases or detergents such as bile salts
or surfactants.
Phylogenically, vertebrate TLRs can be grouped in six fam-
ilies [11]. TLR5 belongs to a unique family and is expressed
both in ﬁshes, birds, rodents and primates. In plants a 22-
mer peptide found in the proximal amino-terminal part of ﬂa-
gellin is recognized by the receptor FLS2 that shares structural
and functional similarities with TLR [32]. Flagellin/FLS2 rec-
ognition takes place on the surface of plant cells and not in
intracellular compartments, in parallel to what happens in
mammalian mucosa.3. Detection of pathogenic motile bacteria in the gut
Intestinal mucosa is specialized in nutrient and water intake
from the lumen. This tissue is heavily colonized by a microbial
ﬂora that participates in digestive functions through degrada-
tion of some dietary substances. Bacterial metabolism also pro-
vides the host with compounds that inﬂuence intestinal gene
expression thereby inﬂuencing the whole gut physiology [33].
The gut is also able to prevent colonization of pathogens with-out compromising the indigenous microﬂora. Remarkably,
commensal as well as pathogenic microorganisms express simi-
lar conserved molecular patterns. Epithelial cells express several
sentinel functions that makes them a central player in innate
surveillance. In addition to the epithelial cells, various mucosal
cell types express PRRs including TLRs. Thus, DCs andmacro-
phages present in the lamina propria may be activated by trans-
located bacteria. Alternatively intraepithelial DCs may directly
interact with luminal PAMPs via dendrites that reach the lumen
between the epithelial cells [34]. While ﬂagellin triggers pro-
inﬂammatory signalling in sentinel cells such as macrophages,
DCs and monocytes upon systemic challenge, less is known
about the contribution of TLR5 signalling by these cells in the
gut [23,35,36]. In contrast, the ﬂagellin-TLR5 system plays a
major role in intestinal innate immunity (Fig. 1C) [37,38], since
many pathogenic bacteria express ﬂagella to colonize mucosa
and likely release ﬂagellin in the lumen [8,28].
Gene proﬁling indicates that ﬂagellin alone recapitulates the
pro-inﬂammatory response triggered by the whole Salmonella
[26,39]. The expression pattern triggered by ﬂagellin corre-
spond to an archetypal TLR signature [40], with the upregula-
tion of (i) a broad-spectrum anti-microbial agents such as
inducible nitric oxide synthase (iNOS), matrilysin (MMP-7),
and human beta-defensin 2 (h-bD2) [8], (ii) chemokines (like
IL-8 or CXCL8) that recruit immune cells, i.e. neutrophils,
macrophages and DCs, into the injured tissue, and (iii) cyto-
kines that together with recruited DCs [41] provide an appro-
priate milieu to mount an adaptive immune response (Fig. 1C)
[8,37]. Flagellin triggers the transient epithelial expression of
the DC-speciﬁc chemokine CCL20 (also known as MIP-3-al-
pha or LARC) that in turn attracts immature DCs [42]. Inter-
estingly, ccl20 expression in Peyer’s patch epithelium is
associated to sub-epithelial positioning of DCs producing
CCR6, the CCL20-speciﬁc receptor and to induction of muco-
sal adaptive immune responses [43,44]. Recruitment of DCs by
epithelial TLR signalling may therefore represent the mecha-
nism coupling innate to adaptive immunity in mucosa.
The distribution of TLR5 along the intestinal epithelium
sheds light on the physiological function of PRR in innate
immunity. In the mouse intestine, TLR5 is expressed in small
intestinal epithelium (our unpublished results) [30,45,46], but
maximally in the caecum and colon epithelium [29,31]. TLR5
is both apical and basolateral in the ileum whereas in colon
expression is restricted to the basolateral membrane. Conse-
quently, epithelial detection of ﬂagellated bacteria in colon re-
lies on bacteria able to deliver ﬂagellin to the basolateral
surface (transepithelial transport), i.e. invasive bacteria or fol-
lowing epithelial breaches. The polarized expression of TLR5
in epithelial cells could reﬂect diﬀerent functional features re-
lated to the bacterial load in the gut segments and the control
of pro-inﬂammatory response. In lower airways where bacteria
are almost not present, epithelial cells express TLR5 at the api-
cal surface (see below).4. TLR-dependent discrimination mechanisms of commensal
versus pathogenic motile bacteria
For many bacterial species, ﬂagellin expression is believed to
take place in the intestinal environment although not experi-
mentally demonstrated. Interestingly bacteria like Brucella or
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recently, been shown to synthesise a ﬂagellum in vitro [47,48].
TLR5-dependent immune response may act as a driving
force for co-evolutive selection of bacterial variants. Thus,
mechanisms may allow bacteria to escape TLR5 detection by
the downregulation or the abrogation of ﬂagellin expression
in vivo or mutations of ﬂagellin capable to form ﬂagellum
but unable to trigger TLR5 activation (Fig. 2B). Firmicutes
but not Bacteroides, both principal indigenous bacteria of
the gut ﬂora are capable to produce pro-inﬂammatory ﬂagellin
in vitro. These bacteria may have been selected for the absence
or the low in vivo expression of ﬂagellin. Moreover, Helicobac-
ter pylori or Campylobacter jejuni, motile bacteria that persis-PR TLR
mucosal
defenses
mucosal
defenses
PR = Pathogen receptor
TLR = MAMP detector
PR + TLR = PAMP detector
Invasive
homeostasis
no signaling?
A
homeostasissignals for
epithelial cells
Lamina propria
macrophage
A
B
Fig. 2. Discrimination of pathogen and commensal by TLR activation at e
Pathogenic bacteria colonize and/or invade epithelial cells and thereby bring m
TLR alone or in combination with pathogen receptor (PR) detect MAMP
(virulence factor or injury) may constitute a PAMP, the proinﬂammatory co
the MAMP and pathogenic moiety. For example, ﬂagellin is the agonist o
complexes may recruit diﬀerent adaptor molecules than TLR alone, giving r
activation may occur within vacuoles or on the basolateral surface of epith
trigger exclusively the innate immune response. (B) TLR-mediated homeosta
host mucosa may use various strategies to activate TLR-dependent homeosta
bacteria by TLR signalling may trigger signalling or activate a gene express
epithelial cells or indirectly via macrophages that, in turn, provide speciﬁc sig
detection by TLR by modiﬁcation of their MAMP expression or structure.
epithelial TLR5 pro-inﬂammatory responses but preserve motility propert
response by downregulating pro-inﬂammatory signalling. In order to pre
inﬂammatory genes, avirulent bacteria can block the degradation of IjB-a, th
cytosol shuttling of NF-jB. Some pathogenic bacteria may also use some oftently colonize the gastric and intestinal environment
produce ﬂagellin mutated in the region equivalent to residues
89–96 of S. typhimurium molecule, thereby impairing TLR5
activation [17,49,50]. Molecular changes within LPS have also
been described, resulting in TLR ignorance or hyporesponsiv-
ness [14,51]. It remains to be established whether such muta-
tions have been selected by commensal bacteria to escape
host innate defences. Alternatively, commensals have devel-
oped strategies to modulate the mucosal immunity. Thus,
pro-inﬂammatory signalling can be turned oﬀ by avirulent Sal-
monella that produce factors that interfere with the intracellu-
lar ubiquitination machinery and, thereby the activation
of NF-jB transcription factor [52]. AvrA, an eﬀector protein pathogenic bacteria
mucosal
defenses
no signaling
No MAMP
ltered MAMP
no signaling
Inhibition
X
pithelial sites. (A) Pro-inﬂammatory epithelial response to pathogens.
icrobe-associated molecular patterns (MAMP) in close contact to cells.
± pathogenic signal. In the latter case, MAMP + pathogenic signal
unterpart of MAMP (left panel). Remarkably, MAMP can carry both
f TLR5 but also binds to gangliosides that may be a PR. TLR–PR
ise to pro-inﬂammatory signalling. For invasive microorganisms, TLR
elial cells. In colon, TLR5 is basolateral: invasive ﬂagellated bacteria
sis and ignorance. Commensal bacteria that live peacefully within the
sis or to prevent pro-inﬂammatory response. Detection of commensal
ion program resulting in homeostasis response. This could operate in
nal to sustain epithelium homeostasis. Microorganisms can also escape
For example, H. pylori produce ﬂagellin that does not trigger per se
ies. Alternatively, bacteria can actively interfere with TLR-mediated
vent nuclear activation of NFjB- dependent transcription of pro-
e cytosol-sequestering molecule of NF-jB or can stimulate the nucleus-
these strategies to escape the TLR-induced defences.
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has been shown to inhibit this activation [53]. Otherwise, Bac-
teroides potentiates the nucleo-cytoplasmic export of NF-jB in
a peroxisome proliferator-activated receptor-c-dependent
manner, thus turning oﬀ the NF-jB-mediated pro-inﬂamma-
tory response (Fig. 2B) [54]. These ﬁndings illustrate the com-
plex crosstalk between host and microﬂora and how
commensals can modulate the host innate immune response.
TLRs were initially deﬁned as receptors that detect patho-
gens. The commensal ﬂora, however, via TLR signalling may
also modulate gut homeostasis and play a role in intestinal re-
newal and repair [2,4]. When TLR signalling is abolished,
either by genetic manipulation using MyD88-deﬁcient mice
or by lowering the levels of molecular patterns from commen-
sal ﬂora using germ-free mice or antibiotic-treated animals, the
diﬀerentiation/proliferation of intestinal epithelium is per-
turbed and expression of proteins that normally act on tissue
healing is impaired. Germ-free or antibiotic-treated mice are
more susceptible to injuries like dextran sodium sulfate
(DSS)-induced colitis and the lesions are reverted by oral
administration of TLR ligands such as LPS. Interestingly,
some TLR ligands induce non-immune cells to proliferate or
prevent them to exit the cell cycle [55]. TLR signalling can also
activate anti-apoptotic pathways and hence control of cell pro-
liferation [56]. Moreover, TLR–MyD88 signalling in macro-
phages close to epithelial stem cells contributes to the healing
process (Fig. 2A) [4].
How do mucosal TLRs discriminate molecular patterns pro-
duced by commensals versus pathogens? Recent ﬁndings from
Svanborg and colleagues shed light on a novel mechanism [57].
They studied the pro-inﬂammatory responses of the bladder
mucosa to uropathogenic bacteria expressing various epithe-
lial-attaching ﬁmbriae. Depending on the ﬁmbriae co-ex-
pressed with bacterial LPS, TLR4 signalling activates various
adaptor molecules (MyD88, TRIF–TRAM) modulating the
signalling cascade and the outcome of the immune response.
The diﬀerential engagement of adaptor molecules may rely
on distinct ﬁmbriae receptors, i.e. surface glycosphingolipids
and mannosylated glycoproteins (Fig. 2B). Pro-inﬂammatory
responses did not occur in the absence of virulence factor.
Modulation of immunity by accessory receptors has also been
shown for yeast b-glucans detected by TLR2 and Dectin-1, a
phagocytic receptor at the surface of macrophages [58]. These
observations suggest that innate responses require both a
molecular pattern-TLR signal and a pathogenic signal. TLR
signalling, that is often reduced to the initial TLR detection,
involves many other co-factors as soluble or membrane mole-
cules. For instance, in the systemic compartment, eﬀective
TLR4 signalling is triggered with the help of LPS-binding pro-
tein, MD-2 and CD14 that may provide additional signals for
TLR activation. However, bladder and intestinal epithelial
cells do not produce several TLR4 co-receptors such as
CD14 and MD-2 and are therefore unresponsive to free LPS
[57,59,60]. One can hypothesize that epithelial cells express
TLRs and particular co-receptors that discriminate pathogen
from commensal by interacting with pathogen-speciﬁc deter-
minants, i.e. virulence factors (Fig. 2B). When a commensal
interacts with epithelial cells, only TLRs are activated, result-
ing in the engagement of a speciﬁc set of adaptor molecules
that turn on homeostatic functions. In response to pathogens,
TLRs act synergistically with co-receptors for virulence factors
thus recruiting additional adaptor molecules resulting in a pro-inﬂammatory response. The TLR adaptor molecule Tollip
strongly expressed by intestinal epithelial cells is believed to
participate in the speciﬁc modulation of TLR signalling [61].
Interestingly, ﬂagellin binds also to gangliosides including asi-
alo-GM1 and this interaction is important for TLR5 signalling
[62,63]. Therefore, ﬂagellin behaves both as a TLR-speciﬁc
molecular pattern and a virulence determinant for epithelial
cells. The contribution of co-receptors and adaptor molecules
in TLR signalling will have to be addressed in future studies.5. Airways response to ﬂagellated bacteria
TLR5-dependent pro-inﬂammatory activation in response
to ﬂagellin is also observed within the epithelial cells lining
the trachea, the bronchi and the alveoli of the respiratory tract
[64–68]. The immune response to Pseudomonas aeruginosa,
Burkholderia cenocepacia, Bordetella bronchiseptica, or Legion-
ella pneumophila is partly or fully recapitulated by ﬂagellin
stimulation as reﬂected by the comparison of the gene expres-
sion proﬁles of intestinal and airway epithelial cells [26,69].
TLR5 signalling after intranasal or intratracheal administra-
tion of ﬂagellin is characterized by the secretion of cytokines/
chemokines and the massive recruitment of neutrophils into
the lung parenchyma and the alveolar compartments [70]. This
process is similar to that observed within TLR-stimulated
bladder mucosa [57]. The aim is to prevent any intrusion and
overgrowth of microorganisms by neutrophil-mediated phago-
cytosis, thereby keeping the mucosa sterile. The contribution
of TLR-induced production of antimicrobial molecules such
as defensins needs still to be addressed.
Recent studies have shown that mucosal administration of
ﬂagellin is associated to strong adaptive immune responses,
especially secretory and serum antibodies [71–73]. These muco-
sal adjuvant properties correlate with the capacity of ﬂagellin
to activate TLR5-positive DCs and/or epithelial cells
[23,71,73]. Flagellin triggers a Th2-response [23,71,72,74] with
the production of mucosal IgAs [23,71,72,74]. This is in part
due to the failure of mouse and human DCs to produce IL-
12 p70 in response to ﬂagellin (Fig. 1C) [23,36]. Epithelial cells
that constitute the main ﬂagellin-reactive cells in the airways
respond to apical TLR5 stimulation by the transient produc-
tion of CCL20 that attract immature DCs (Fig. 1C) [75,76].
The respective contribution of resident versus recruited DCs
in the development of ﬂagellin-mediated mucosal response re-
mains to be determined.
Finally, host molecules with repetitive sequences like hyalu-
ronan-derived products are able to interact with TLRs and in-
duce responses that control airway epithelial homeostasis,
especially during lung repair and remodelling following
inﬂammation [5].6. Immunopathologies associated to TLR5
The importance of ﬂagellin-mediated TLR5 signalling in
mucosal immune responses has been highlighted by recent epi-
demiological and genetic studies. Hawn et al. described a ge-
netic polymorphism of human TLR5 coding for a deleted
molecule: TLR5392-stop with an allele frequency of 10%. This
variant functions as a dominant negative molecule on wild
type TLR5 [21]. Individuals carrying this allele are more sus-
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expressing low levels of TLR5 are more susceptible to systemic
S. typhimurium infection. Whether these mice are more suscep-
tible to mucosal infection has not been assessed [77]. In con-
trast, there is no enhanced prevalence of infection with S.
typhi, the causative agent of typhoid fever, in individuals that
are heterozygote or homozygote for TLR5392-stop. Whether ﬂa-
gellin is not essential or poorly expressed during some crucial
invasion phases remains to be established [78].
The role of TLR5 in controlling mucosal colonization is also
supported by some recent ﬁndings in Crohn’s disease. This
multi-factorial pathology is a chronic bowel inﬂammation
characterized by an increased permeability of the mucosa to
environmental materials and an uncontrolled innate and adap-
tive immune response against the gut ﬂora. Mutations in the
gene encoding NOD2, a cytosolic detector of microbial pepti-
doglycans, are found in a subpopulation of patients with
Crohn’s disease [79]. Various studies showed a strong serum
antibody response speciﬁc for ﬂagellin of commensal bacteria
in subjects suﬀering Crohn’s disease but not ulcerative colitis
[80–83]. In the DSS-induced mouse colitis model, intra-colonic
administration of ﬂagellin aggravates the prognosis [31]. In
addition, a negative association between TLR5392-stop allele
and Crohn’s disease was described among ashkenazi Jews
[83]. Finally, it has been noticed that TLR5 expression is un-
changed or downregulated in the mucosa of subjects suﬀering
colitis whereas TLR4 expression is strongly enhanced [84].
Noticeably, an association between susceptibility to colitis
and diﬀerences in innate signalling of TLRs and Nod2 ligands
was shown to depend on NF-jB p50 subunit [85]. Altogether,
these data suggest that early TLR5-mediated innate and adap-
tive responses may cause the onset of inﬂammation. How
TLRs and Nod2 cooperate and aﬀect the bacterial recognition
and the outcome of inﬂammatory bowel diseases remains to be
established.
TLR5 signalling may also inﬂuence the systemic response. In
fact, TLR5392-stop is associated with resistance to systemic ery-
thematosus lupus (SLE), a chronic autoimmune disease char-
acterized in part by anti-DNA antibodies [86]. Even if the
role of TLR5 in SLE is not clear, it raises the possibility that
ﬂagellin-mediated stimulation in susceptible individuals may
contribute to the induction of pathogenic immune responses.7. Concluding remarks
Contribution of PRR in mucosal tissues has only recently
been studied. Among PPRs, TLRs play a crucial role in detect-
ing danger signals and triggering innate immune response that
prevent pathogens from invading the host and spreading sys-
temically. Other host molecules expressed at the mucosal sur-
faces are likely to participate in such defence mechanisms as
shown for uropathogenic E. coli infection of the bladder. PPRs
are also involved in mediating epithelial homeostatic functions
facilitating mucosal tissue repair and remodelling following
inﬂammation. Among PRRs, TLR5 has a unique function
since it links innate and adaptive responses by recruiting
DCs the only antigen-presenting cells able to activate naı¨ve
T cells. Whether TLR5 participates in bacterial clearance
and/or immunopathological processes will require studies in
knockout and transgenic animals.How pathogens and commensals stimulate distinct mucosal
responses although expressing similar molecular patterns starts
to be understood. Recently it has been shown that commensals
are able to modulate pro-inﬂammatory responses by interfering
with TLR signalling cascades. Pathogens use additional viru-
lence factors that participate in the onset of pro-inﬂammatory
responses. Thus, the wide variety of responses to the myriad
of microorganisms may be explained by the diversity of core-
ceptors that can be engaged to induce functional TLR signal-
ling. The commensal mediated speciﬁc TLR/MyD88 pathway
allows the lasting ‘‘entente cordiale’’ between the microﬂora
and the host, while pathogen-speciﬁc virulence factors are re-
quired to trigger transient pro-inﬂammatory responses via the
usage of additional TLR coreceptor and adaptor molecules.
Finally, we have to keep in mind that TLR activation in mu-
cosa usually does not occur as a global mucosal signalling but
remains focalized to limited areas where infection takes place.
When the entire mucosal tissues get activated through TLR
signalling, the outcome is reminiscent to what is seen in septic
shock with a systemic activation of the innate immune system.
Since this situation is the most common in experimental set-
tings, novel assays have to be developed to shed light on the
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